Market Overview:
The global activated clotting time testing market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of thrombotic disorders, technological advancements in activated clotting time testing devices, and rising demand for point-of-care (POC) tests. However, the high cost of advanced activated clotting time testing devices may restrain the growth of this market during the forecast period. Based on type, the global activated clotting time testing market is segmented into optical detection, laser-based detection, mechanical detection, fluorescent based detection and others. Optical detection is further subsegmented into reflectance photometry and transmission photometry; laser-based detection is further subsegmented into single wavelength laser light scattering (SWLLS) and multiwavelength laser light scattering (MWLLS); mechanical Detection is further subsegmented into pipettes/pumps and microfluidics; fluorescent based Detection are divided into two segments: fluorescence polarization immunoassay (FPIA) assay and chemiluminescence immunoassay (CLIA). By application, hospitals accounted for majority share in 2017 owing to rising number of surgeries performed in hospitals across globe coupled with growing demand for POC tests.
Product Definition:
Activated clotting time (ACT) is a blood test that measures how long it takes for a blood sample to form a clot. The ACT is used as an indicator of how well the patient's blood clots.
Optical Detection:
Optical detection is a technology that uses visible light or other electromagnetic radiation to detect the presence, size, and location of an object. It is different from X-ray based technologies as it does not use ionizing radiation (X-rays) to identify objects. The optical detection system works by directing the light onto the blood sample and then detecting any blood particles that react with the light.
Laser-based Detection:
Laser-based detection is a method of detecting blood clots using focused laser beams. It provides accurate results in less time with high sensitivity and specificity. Activated clotting time testing is used to detect the length of time taken by blood to coagulate or clot after an injury or trauma has occurred. This test helps in determining the appropriate treatment for patients suffering from life-threatening bleeding disorders such as hemophilia and Von Willebrand disease (VWD).
Application Insights:
The market is segmented based on application into hospitals, clinical laboratories, ambulatory surgical centers, academic and research institutes and others. The hospital segment dominated the global activated clotting time testing market in 2017 due to factors such as a high prevalence of coagulation disorders that require anticoagulant treatment along with an increase in the number of surgeries being performed. According to data published by CDC in 2014, around 1 out of every 3 deaths occur during surgery which indicates a significant opportunity for advanced diagnostic devices such as ATD's within hospitals.
In addition, growing awareness about these tests among healthcare professionals coupled with technological advancements has led to an increased adoption rate across various settings including clinics and primary care facilities.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement scenario. In addition, increasing cases of stroke and heart attacks are expected to drive demand for activated clotting time testing products in this region. For instance, according to a study published by American Heart Association (AHA), every year around 6 million people suffer from heart attacks in U.S., with one-third having no clue about their condition at the time of occurrence which results into permanent disability or death for 1 out of 3 patients suffering from acute myocardial infarction (AMI).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments as well as private sectors coupled with growing awareness among individuals regarding risk factors associated with cardiovascular diseases such as hypertension.
Growth Factors:
- Increasing incidence of thromboembolic disorders: The global activated clotting time testing market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing incidence of thromboembolic disorders such as deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Growing demand for point-of-care testing: The growing demand for point-of-care testing is another key growth driver for the activated clotting time testing market. This can be attributed to the advantages offered by these tests, such as faster turnaround time and ease of use.
- Technological advancements in clotting assays: The technological advancements in clotting assays are also propelling the growth of the activated clotting time testing market. These advancements are helping laboratories to improve their workflow and increase accuracy and precision in results interpretation.
- Rising geriatric population: The rising geriatric population is another major factor driving growth in this market, as elderly patients are more susceptible to developing blood clots than younger patients due to various physiological changes that occur with age, including alterations in blood composition and reduced mobility levels.. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Activated Clotting Time Testing Market Research Report
By Type
Optical Detection, Laser-based Detection, Mechanical Detection, Fluorescent Based Detection,
By Application
Hospitals, Clinical Laboratories, Ambulatory Surgical Center, Academic & Research Institutes, Others,
By Companies
Roche, Thermo Fisher Scientific, Abbott, Helena Laboratories, Sysmex, Medtronic, Instrumentation Laboratory, Diagnostica Stago, Werfen, LabCorp,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Activated Clotting Time Testing Market Report Segments:
The global Activated Clotting Time Testing market is segmented on the basis of:
Types
Optical Detection, Laser-based Detection, Mechanical Detection, Fluorescent Based Detection,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinical Laboratories, Ambulatory Surgical Center, Academic & Research Institutes, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Thermo Fisher Scientific
- Abbott
- Helena Laboratories
- Sysmex
- Medtronic
- Instrumentation Laboratory
- Diagnostica Stago
- Werfen
- LabCorp
Highlights of The Activated Clotting Time Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Optical Detection
- Laser-based Detection
- Mechanical Detection
- Fluorescent Based Detection
- By Application:
- Hospitals
- Clinical Laboratories
- Ambulatory Surgical Center
- Academic & Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Activated Clotting Time Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Activated clotting time testing is a laboratory test that measures the time it takes for blood to clot after being injected into a vein. The test is used to determine if someone has an abnormal blood clotting time.
Some of the key players operating in the activated clotting time testing market are Roche, Thermo Fisher Scientific, Abbott, Helena Laboratories, Sysmex, Medtronic, Instrumentation Laboratory, Diagnostica Stago, Werfen, LabCorp.
The activated clotting time testing market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Activated Clotting Time Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Activated Clotting Time Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Activated Clotting Time Testing Market - Supply Chain
4.5. Global Activated Clotting Time Testing Market Forecast
4.5.1. Activated Clotting Time Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Activated Clotting Time Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Activated Clotting Time Testing Market Absolute $ Opportunity
5. Global Activated Clotting Time Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Activated Clotting Time Testing Market Size and Volume Forecast by Type
5.3.1. Optical Detection
5.3.2. Laser-based Detection
5.3.3. Mechanical Detection
5.3.4. Fluorescent Based Detection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Activated Clotting Time Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Activated Clotting Time Testing Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinical Laboratories
6.3.3. Ambulatory Surgical Center
6.3.4. Academic & Research Institutes
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Activated Clotting Time Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Activated Clotting Time Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Activated Clotting Time Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Activated Clotting Time Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Activated Clotting Time Testing Demand Share Forecast, 2019-2026
9. North America Activated Clotting Time Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Activated Clotting Time Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Activated Clotting Time Testing Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinical Laboratories
9.4.3. Ambulatory Surgical Center
9.4.4. Academic & Research Institutes
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Activated Clotting Time Testing Market Size and Volume Forecast by Type
9.7.1. Optical Detection
9.7.2. Laser-based Detection
9.7.3. Mechanical Detection
9.7.4. Fluorescent Based Detection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Activated Clotting Time Testing Demand Share Forecast, 2019-2026
10. Latin America Activated Clotting Time Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Activated Clotting Time Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Activated Clotting Time Testing Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinical Laboratories
10.4.3. Ambulatory Surgical Center
10.4.4. Academic & Research Institutes
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Activated Clotting Time Testing Market Size and Volume Forecast by Type
10.7.1. Optical Detection
10.7.2. Laser-based Detection
10.7.3. Mechanical Detection
10.7.4. Fluorescent Based Detection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Activated Clotting Time Testing Demand Share Forecast, 2019-2026
11. Europe Activated Clotting Time Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Activated Clotting Time Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Activated Clotting Time Testing Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinical Laboratories
11.4.3. Ambulatory Surgical Center
11.4.4. Academic & Research Institutes
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Activated Clotting Time Testing Market Size and Volume Forecst by Type
11.7.1. Optical Detection
11.7.2. Laser-based Detection
11.7.3. Mechanical Detection
11.7.4. Fluorescent Based Detection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Activated Clotting Time Testing Demand Share, 2019-2026
12. Asia Pacific Activated Clotting Time Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Activated Clotting Time Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Activated Clotting Time Testing Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinical Laboratories
12.4.3. Ambulatory Surgical Center
12.4.4. Academic & Research Institutes
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Activated Clotting Time Testing Market Size and Volume Forecast by Type
12.7.1. Optical Detection
12.7.2. Laser-based Detection
12.7.3. Mechanical Detection
12.7.4. Fluorescent Based Detection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Activated Clotting Time Testing Demand Share, 2019-2026
13. Middle East & Africa Activated Clotting Time Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Activated Clotting Time Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Activated Clotting Time Testing Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinical Laboratories
13.4.3. Ambulatory Surgical Center
13.4.4. Academic & Research Institutes
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Activated Clotting Time Testing Market Size and Volume Forecast by Type
13.7.1. Optical Detection
13.7.2. Laser-based Detection
13.7.3. Mechanical Detection
13.7.4. Fluorescent Based Detection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Activated Clotting Time Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Activated Clotting Time Testing Market: Market Share Analysis
14.2. Activated Clotting Time Testing Distributors and Customers
14.3. Activated Clotting Time Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Helena Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sysmex
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Medtronic
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Instrumentation Laboratory
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Diagnostica Stago
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Werfen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. LabCorp
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
